- Home
- GNLN vs AWH Comparison
GNLN vs AWH Comparison
Compare GNLN & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- AWH
- Stock Information
- Founded
- GNLN 2005
- AWH 1993
- Country
- GNLN United States
- AWH United States
- Employees
- GNLN N/A
- AWH N/A
- Industry
- GNLN Durable Goods
- AWH Medical/Dental Instruments
- Sector
- GNLN Consumer Discretionary
- AWH Health Care
- Exchange
- GNLN Nasdaq
- AWH Nasdaq
- Market Cap
- GNLN 1.6M
- AWH 1.6M
- IPO Year
- GNLN 2019
- AWH N/A
- Fundamental
- Price
- GNLN $0.27
- AWH $0.10
- Analyst Decision
- GNLN
- AWH Buy
- Analyst Count
- GNLN 0
- AWH 2
- Target Price
- GNLN N/A
- AWH $4.40
- AVG Volume (30 Days)
- GNLN 385.8K
- AWH 12.9M
- Earning Date
- GNLN 03-21-2025
- AWH 03-27-2025
- Dividend Yield
- GNLN N/A
- AWH N/A
- EPS Growth
- GNLN N/A
- AWH N/A
- EPS
- GNLN N/A
- AWH N/A
- Revenue
- GNLN $13,275,000.00
- AWH $9,182,000.00
- Revenue This Year
- GNLN $1,541.21
- AWH $11.87
- Revenue Next Year
- GNLN N/A
- AWH $79.10
- P/E Ratio
- GNLN N/A
- AWH N/A
- Revenue Growth
- GNLN N/A
- AWH 0.31
- 52 Week Low
- GNLN $0.26
- AWH $0.08
- 52 Week High
- GNLN $21.80
- AWH $3.63
- Technical
- Relative Strength Index (RSI)
- GNLN 17.91
- AWH 28.07
- Support Level
- GNLN $0.26
- AWH $0.09
- Resistance Level
- GNLN $0.37
- AWH $0.36
- Average True Range (ATR)
- GNLN 0.05
- AWH 0.01
- MACD
- GNLN 0.01
- AWH 0.01
- Stochastic Oscillator
- GNLN 0.76
- AWH 15.00
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a distributor of vaporization products and consumption accessories in the United States. It offers a selection of stock-keeping units including vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. The company markets and sells its products in both the business to business and business to consumer sectors of the marketplace. Its geographical segment includes the United States; Canada and Europe. It derives a majority of revenue from the United States.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.